L vs VYGR · P/E 14, rev $18.45B vs rev $80.0M
Loews Corp (L) versus Voyager Therapeutics Inc (VYGR) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
Latest reported VYGR revenue for 2024-12-31 was $80.0M. Net income was -$65.0M. Revenue was down 68.0% from 2023-12-31 to 2024-12-31. VYGR currently screens at market cap $225.4M.
L currently screens at market cap $22.36B and trailing P/E 13.8. VYGR currently screens at market cap $225.4M.
Not investment advice. Open the L and VYGR stock pages for the full models.
Not investment advice.